2022
DOI: 10.1080/13697137.2022.2073809
|View full text |Cite
|
Sign up to set email alerts
|

Resveratrol promotes bone mass in ovariectomized rats and the SIRT1 rs7896005 SNP is associated with bone mass in women during perimenopause and early postmenopause

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 35 publications
0
6
0
Order By: Relevance
“… BV/TV Analysis of 18 studies [ 15 , 25 27 , 30 , 33 , 35 38 , 40 , 41 ] showed that, compared with those in the control group, the BV/TV in the Res group was markedly greater ( n = 252; SMD, 1.44; 95% CI, 0.68 to 2.19; I 2 = 80%, P < 0.001). Tb.N Analysis of 18 studies [ 19 , 25 27 , 33 , 35 38 , 40 , 41 ] showed that, compared with the control group, the Res group had markedly greater total bilirubin (Tb.N) ( n = 242; SMD, 1.68; 95% CI, 0.95 to 2.42; I 2 = 74%, P < 0.00001). Tb.Th Analysis of 18 studies [ 19 , 25 , 26 , 30 , 33 , 35 37 , 40 , 41 ] showed that, compared with that in the control group, the Tb.Th in the Res group was markedly greater ( n = 248; SMD, 1.73; 95% CI, 1.09 to 2.37; I 2 = 71%, P < 0.00001).…”
Section: Secondary Outcomesmentioning
confidence: 99%
See 2 more Smart Citations
“… BV/TV Analysis of 18 studies [ 15 , 25 27 , 30 , 33 , 35 38 , 40 , 41 ] showed that, compared with those in the control group, the BV/TV in the Res group was markedly greater ( n = 252; SMD, 1.44; 95% CI, 0.68 to 2.19; I 2 = 80%, P < 0.001). Tb.N Analysis of 18 studies [ 19 , 25 27 , 33 , 35 38 , 40 , 41 ] showed that, compared with the control group, the Res group had markedly greater total bilirubin (Tb.N) ( n = 242; SMD, 1.68; 95% CI, 0.95 to 2.42; I 2 = 74%, P < 0.00001). Tb.Th Analysis of 18 studies [ 19 , 25 , 26 , 30 , 33 , 35 37 , 40 , 41 ] showed that, compared with that in the control group, the Tb.Th in the Res group was markedly greater ( n = 248; SMD, 1.73; 95% CI, 1.09 to 2.37; I 2 = 71%, P < 0.00001).…”
Section: Secondary Outcomesmentioning
confidence: 99%
“… Tb.Th Analysis of 18 studies [ 19 , 25 , 26 , 30 , 33 , 35 37 , 40 , 41 ] showed that, compared with that in the control group, the Tb.Th in the Res group was markedly greater ( n = 248; SMD, 1.73; 95% CI, 1.09 to 2.37; I 2 = 71%, P < 0.00001). Tb.Sp Analysis of 20 studies [ 19 , 25 27 , 30 , 33 , 35 38 , 40 , 41 ] showed that, compared with that in the control group, the Tb.Sp in the Res group was markedly lower ( n = 278; SMD, − 1.76; 95% CI, − 2.35 to − 1.16; I 2 = 70%, P < 0.00001). …”
Section: Secondary Outcomesmentioning
confidence: 99%
See 1 more Smart Citation
“…RES positively regulates osteogenic differentiation by inhibiting the expression of miRNA-338-3p and inhibits osteoclast proliferation by stimulating the expression of miRNA-92-b-3p [26,27] . The oral administration of RES to OVX rats and post-menopausal women improves the bone loss due to estrogen-deficiency, increases bone mass and reduces bone resorption [25] . Moreover, RES intake increases bone mass in women who do not take calcium or vitamin D and strengthens the increase of lumbar BMD in women who take calcium and/or vitamin D [28] .…”
Section: Resveratrol and Curcuminmentioning
confidence: 99%
“…Studies in vitro demonstrated that RES exerts its anti-osteoporotic effect by inhibiting the p53 signalling pathway [22] , improving the osteogenic differentiation into BM-SCs [23] and up-regulating FOXO1 transcriptional activity [24] . OPG and β-catenin are increased by RES that, on the contrary, decreases RANKL by stimulating Sirt-1 expression [24,25] . RES positively regulates osteogenic differentiation by inhibiting the expression of miRNA-338-3p and inhibits osteoclast proliferation by stimulating the expression of miRNA-92-b-3p [26,27] .…”
Section: Resveratrol and Curcuminmentioning
confidence: 99%